Accelerate Diagnostics Announces 1-for-10 Reverse Stock Split

/PRNewswire/ -- Accelerate Diagnostics, Inc., (NASDAQ: AXDX) (the "Company") a leading provider of innovative rapid diagnostic solutions, announced that it

Breast cancer test results 'outstanding

Inline XBRL Viewer

ful-def14a_20230406.htm

AXDX stock news Accelerate Diagnostics latest news - TipRanks

Accelerate Diagnostics Inc. to undergo 1-for-10 reverse stock split - Phoenix Business Journal

Biosensor developer Know Labs goes public on the NYSE

A New survey of the Needham Question

SEC Filing Caribou Biosciences, Inc.

Inhibikase Therapeutics Announces a 1-for-6 Reverse Stock Split

Accelerate Diagnostics Announces 1-for-10 Reverse Stock Split

10-K

Reverse Stock Split

Combined PARP and HSP90 inhibition: preclinical and Phase 1 evaluation in patients with advanced solid tumours

Share Market Highlights 13 December 2023: Sensex, Nifty end marginally higher; IT stocks drag - The Hindu BusinessLine